Foster City, CA, United States of America

Guoxian Wu

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 8.4

ph-index = 21

Forward Citations = 1,594(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2007 - 2020)
  • Foster City, CA (US) (2006 - 2024)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
Loading Chart...
43 patents (USPTO):

Title: Guoxian Wu: Innovator in Kinase Modulation

Introduction

Guoxian Wu is an accomplished inventor based in Foster City, CA, with an impressive portfolio of 43 patents. His work primarily focuses on the modulation of protein kinases, which play a crucial role in various biological processes and diseases.

Latest Patents

Two of Guoxian Wu’s most recent patents include "Compounds and methods for kinase modulation, and indications therefor," which describes compounds active on protein kinases and their use in treating diseases associated with abnormal kinase activity. Another significant patent is "Compounds and methods for EP300 or CBP modulation and indications therefor," which discloses compounds of Formula I aimed at modifying the activity of certain proteins involved in cellular functions.

Career Highlights

Throughout his career, Guoxian has made significant contributions to the fields of biology and medicinal chemistry while working with renowned companies such as Plexxikon Inc. and Medarex Inc. His innovative approaches to drug development have paved the way for potential treatments that could improve patient outcomes in various pathological conditions.

Collaborations

Guoxian Wu has collaborated with notable peers in the industry, including Prabha N Ibrahim and Wayne Spevak. These partnerships have undoubtedly enhanced his research and the effectiveness of his innovative compounds.

Conclusion

Guoxian Wu's extensive patent portfolio and his dedication to advancing kinase modulation research highlight his status as a leading inventor in the biotechnology sector. His work continues to hold promise for the development of novel therapeutic strategies for challenging diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…